Highlights

• Rubicon Research shares have surged over 103% on a year-to-date basis.
• Stock trades close to its 52-week high of INR 1,400.
• FY26 net profit rose nearly 60% year-on-year on a consolidated basis.

Rubicon Research Limited (NSE:RUBICON) remained in focus on June 17 after its shares traded near a fresh 52-week high, extending gains generated over recent months. The pharmaceutical company has witnessed significant investor interest, with the stock more than doubling since the beginning of 2026.

At 2:20 PM IST, Rubicon Research shares were trading at INR 1,375, up 1.73% from the previous close of INR 1,351.60. During the session, the stock touched an intraday high of INR 1,384.90 and remained close to its 52-week high of INR 1,400 recorded on June 16.

Source: Analysis by Kalkine 

FY26 Earnings Show Strong Growth

The company's latest financial results indicated notable earnings growth. For the quarter and year ended March 31, 2026, Rubicon Research reported consolidated total income of INR 51,652.5 lakh. Consolidated profit before tax stood at INR 9,868.7 lakh, while net profit reached INR 7,678.5 lakh.

On a standalone basis, total income came in at INR 39,345.9 lakh, with profit before tax of INR 9,418.5 lakh and net profit of INR 7,002 lakh.

Profitability Improves Significantly

Based on the reported figures, consolidated net profit increased from approximately INR 4,799 lakh in FY25 to INR 7,679 lakh in FY26. This represents a year-on-year increase of around 60%.

Consolidated earnings per share also increased to INR 4.66 for FY26. The earnings growth has coincided with the stock's strong market performance over recent months.

Stock Trades Close to Record Levels

Rubicon Research has experienced a substantial rerating since its 52-week low of INR 570.75 recorded on October 24, 2025. At the current market price of INR 1,375, the stock is trading nearly 141% above its 52-week low and less than 2% below its recent 52-week high.

Trading activity remained active, with approximately 2 lakh shares changing hands during the session, generating traded value of around INR 27.18 crore.

Valuation and Market Indicators

The stock is currently classified under ASM Stage-1 surveillance. Exchange data also indicates that the company's trailing four-quarter price-to-earnings ratio remains above 50 times.

While investor interest has remained elevated, the sharp appreciation in the share price means market participants may continue to monitor earnings growth, valuation metrics, and future business performance closely.

Triple-Digit Returns Drive Investor Attention

Rubicon Research has delivered substantial gains across multiple timeframes. The stock has risen 15.78% over the past week and 43.15% over the last month. On a year-to-date basis, shares have advanced 103.34%, significantly outperforming the NIFTY Total Market Index, which declined 3.04% during the same period.

The sharp rise has lifted the company's market capitalisation to approximately INR 22,710 crore, while its free-float market capitalisation stood at about INR 3,125 crore.

Source: NSE

Key Risks

• Elevated valuation levels may increase volatility.
• ASM surveillance can affect trading sentiment.
• Earnings growth may be closely scrutinised by investors.
• Sharp price appreciation could trigger profit booking.

Summary

Rubicon Research shares traded near their 52-week high after delivering more than 103% year-to-date returns. The pharmaceutical company reported consolidated FY26 net profit of INR 7,678.5 lakh, reflecting approximately 60% growth from the previous year. With the stock trading nearly 141% above its 52-week low and close to record levels, investors are closely tracking earnings performance, valuation trends, and future growth execution.

FAQs

Q: How much has Rubicon Research stock gained in 2026?
A: The stock has delivered approximately 103.34% year-to-date returns as of June 17, 2026.

Q: What was Rubicon Research's FY26 consolidated net profit?
A: Consolidated net profit stood at INR 7,678.5 lakh for FY26.

Q: How close is the stock to its 52-week high?
A: The share price is trading less than 2% below its 52-week high of INR 1,400.